目前预防和治疗急性和慢性GVHD的方法
Attilio Olivieri1, Giorgia Mancini2
1Clinica di Ematologia, Università Politecnica delle Marche Ancona, 60126 Ancona, Italy.
Cells
|September 27, 2024
概括
急性和慢性移植对宿主疾病 (GVHD) 需要不同的管理策略. 皮质类固醇和鲁克索利提尼布是关键的治疗方法,新兴的治疗方法如Belumosudil和Axatilimab对耐火性慢性GVHD有希望.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 移植与宿主疾病 (GVHD) 是异性干细胞移植 (HSCT) 的一个重要并发症.
- 急性GVHD (aGVHD) 主要涉及炎症,而慢性GVHD (cGVHD) 呈现出自身免疫和纤维化的特征.
- aGVHD是发展cGVHD的一个主要风险因素.
研究的目的:
- 审查aGVHD和cGVHD目前的预防和治疗策略.
- 突出GVHD管理中的新兴疗法和挑战.
- 强调在完善风险分层和治疗选择方面需要生物标志物.
主要方法:
- 审查关于GVHD预防和治疗的当前文献.
- 讨论标准治疗方法,包括氨酸抑制剂 (CNI),甲甲 (MTX),甲 (MMF),皮质类固醇和鲁克索利提尼布.
- 探索研究方法,如移植后环胺 (PTCy),阿巴塔塞普特,中介细胞干细胞,微生物移植,体外光聚合 (ECP),贝卢莫苏迪尔,阿克萨利马布和阿尔维莱斯塔特.
主要成果:
- 标准预防包括CNI与MTX或MMF.
- 皮质类固醇是aGVHD的第一线治疗,而鲁克索利提尼布是二线治疗.
- 鲁克索利提尼布是固醇耐火性cGVHD的标准;贝卢莫苏迪尔和阿克萨利马布对鲁克索利提尼布耐火性cGVHD有希望.
- 支气管炎消灭综合征 (BOS) 仍然具有挑战性,而Alvelestat显示出潜力.
- 生物标志物对于个性化风险分层和治疗至关重要.
结论:
- 根据疾病阶段和特征进行量身定制的方法来管理GVHD.
- 鲁克索利提尼布已成为耐火性GVHD的标准,新的药物提供了更多的选择.
- 了解GVHD病理生理学的进步推动了向治疗的发展,以及对可靠生物标志物的关键需求.
更多相关视频
09:50Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
Published on: February 11, 2019
9.7K
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
7.1K
相关概念视频
Cell-mediated Immune Responses
67.8K
Overview
67.8K
Bone Marrow Sampling and Transplants
313
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
313
Tissue Transplantation
343
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
343
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Kidney Transplant II: Surgical Procedure
2
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
2
Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
